Treating hypertension: it is not how you start but where you end that matters

B Williams - Journal of hypertension, 2003 - journals.lww.com
There are many different drug classes available for the treatment of hypertension and new
classes continue to emerge. This has been fertile ground for drug development as …

Global impact of the 2017 American College of Cardiology/American Heart Association hypertension guidelines: a perspective from Italy

G Mancia, G Corrao - Circulation, 2018 - Am Heart Assoc
February 27, 2018 Circulation. 2018; 137: 889–890. DOI: 10.1161/CIRCULATIONAHA.
117.032850 890 ministration of≥ 2 drugs when BP control is inadequate, a phenomenon …

Therapeutic controversies in hypertension

FH Messerli, E Grossman - Seminars in nephrology, 2005 - Elsevier
Although numerous prospective randomized trials since the Veterans Administration studies
clearly have attested to the efficacy and safety of antihypertensive therapy, there remain …

Hypertension Update: Current Guidelines.

AJ Viera - FP essentials, 2018 - europepmc.org
Hypertension affects at least 1 in 3 American adults and is a major contributor to premature
mortality. Current guidelines recommend screening all adults for hypertension. Ambulatory …

[HTML][HTML] Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases …

SE Kjeldsen, BM Egan, M Burnier, K Narkiewicz… - Blood …, 2024 - Taylor & Francis
The 2023 Guidelines of the European Society of Hypertensin (ESH)[1] contain several
novelties though numerous ground pillars in the management of hypertension remain as …

Pharmacologic treatment of hypertension

CVS Ram, EV Lerma - Nephrology Secrets, 2012 - Elsevier
When an individual's blood pressure (BP) does not fall below goal after a suitable period of
intensive lifestyle modifications, antihypertensive drug therapy is universally recommended …

Evaluation of recent fixed-dose combination therapies in the management of hypertension

A Khanna, L Lefkowitz, WB White - Current Opinion in Nephrology …, 2008 - journals.lww.com
Combination therapy of antihypertensive agents (eg angiotensin-converting enzyme
inhibitor/calcium channel blocker, angiotensin-converting enzyme inhibitor/diuretics, and …

Clinical Trials: Evidence and Unanswered Questions–Hypertension

DS Celermajer - Cerebrovascular Diseases, 2003 - karger.com
Since the pioneering publications of the Hypertension Detection and Follow-up Program
(HDFP) and the Multiple Risk Factor Intervention Trial (MRFIT) in the late 1970s and early …

The management and treatment of hypertension

FW Germino - Clinical cornerstone, 2009 - Elsevier
High blood pressure (HBP) is one of the most prevalent conditions seen today by clinicians,
affecting an estimated 73 million–or 1 in 3—adult Americans, only one third of whom have …

Improvement in hypertension management with pharmacological and non-pharmacological approaches: current perspectives

D Hong, W Shan - Current Pharmaceutical Design, 2021 - ingentaconnect.com
Purpose: Improving hypertension management is still one of the biggest challenges in public
health worldwide. Existing guidelines do not reach a consensus on the optimal Blood …